Mineralys Therapeutics, Inc. (MLYS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$170.60M | +11.3% |
| 2024 | -$192.40M | -127.3% |
| 2023 | -$84.66M | -168.9% |
| 2022 | -$31.48M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$170.60M | +11.3% |
| 2024 | -$192.40M | -127.3% |
| 2023 | -$84.66M | -168.9% |
| 2022 | -$31.48M | — |